AbCellera Biologics (ABCL) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.16
-0.14
-0.12
-0.1

Details

Expected EPS
-0.125467
Actual EPS
-0.14
Surprise EPS
-0.01
Surprise Percent
+11.58%

Description

AbCellera Biologics (ABCL) has reported earnings of -0.14 per share for Q2 2024.

0 Comments

Share your thoughts